Carol Karp
Consejero General en PROTHENA CORPORATION PLC .
Fortuna: - $ al 31/05/2024
Perfil
Carol D.
Karp is currently the Vice Chairman-Trustees Board at Rochester Christian University and the Chief Regulatory Officer at Prothena Corp.
Plc.
Previously, she held positions as an Officer at VIVUS, Inc., SVP-Regulatory Affairs, Quality & Drug Safety at CV Therapeutics, Inc., Senior VP-Regulatory Affairs & Compliance at Esperion Therapeutics, Inc., Vice President-Scientific Affairs at Powderject Technologies BV, and Vice President & Head-Global Regulatory Affairs at Janssen Alzheimer Immunotherapy.
She obtained her undergraduate degrees from Rochester Christian University and New York University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PROTHENA CORP. PLC
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Carol Karp
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTHENA CORPORATION PLC | Consejero General | 15/12/2016 |
| Rochester Christian University | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Carol Karp.
| Empresas | Cargo | Fin |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Oficial de Cumplimiento | 01/01/2014 |
| Janssen Alzheimer Immunotherapy | Consejero General | 01/01/2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Consejero General | 02/05/2011 |
| VIVUS, INC. | Corporate Officer/Principal | - |
| Powderject Technologies BV | Director Técnico/Científico/I+D | - |
Formación de Carol Karp.
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Empresas privadas | 4 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
| Janssen Alzheimer Immunotherapy |
- Bolsa de valores
- Insiders
- Carol Karp
